Novartis Investigative Site

New Territories, Hong Kong 999077

0 studies enrolling now · 4 studies all time

What they study most

CD79 Mutant or ABC-subtype Diffuse Large B-Cell Lymphoma, Multiple Myeloma, Primary Immune Thrombocytopenia (ITP), Pulmonary Disease, Chronic Obstructive

Studies at this site

• Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP) — Running, not enrolling
• Dose-range Finding Efficacy and Safety Study for QBW251 in COPD Patients — Completed
• Safety and Efficacy of AEB071 and EVEROLIMUS in Patients With CD79-mutant or ABC Subtype Diffuse Large B-Cell Lymphoma — Completed
• Panobinostat or Placebo With Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma — Completed